Sleep

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Sleep

Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T

The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.

Sleep

Krystal AD

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

Sleep

Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T

NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.

Sleep

Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR

The empirical identification of insomnia subtypes: a cluster analytic approach.

Sleep

Edinger JD, Fins AI, Goeke JM, McMillan DK, Gersh TL, Krystal AD, McCall WV

Pages